BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 18072726)

  • 1. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
    J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
    Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
    Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib prodrugs possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Velázquez CA; Huang Z; Dong Y; Das D; Yu G; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4544-9. PubMed ID: 20576432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
    Penning TD; Talley JJ; Bertenshaw SR; Carter JS; Collins PW; Docter S; Graneto MJ; Lee LF; Malecha JW; Miyashiro JM; Rogers RS; Rogier DJ; Yu SS; AndersonGD ; Burton EG; Cogburn JN; Gregory SA; Koboldt CM; Perkins WE; Seibert K; Veenhuizen AW; Zhang YY; Isakson PC
    J Med Chem; 1997 Apr; 40(9):1347-65. PubMed ID: 9135032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors.
    Chandna N; Kumar S; Kaushik P; Kaushik D; Roy SK; Gupta GK; Jachak SM; Kapoor JK; Sharma PK
    Bioorg Med Chem; 2013 Aug; 21(15):4581-90. PubMed ID: 23769654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
    Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
    J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.
    Singh SK; Vobbalareddy S; Kalleda SR; Rajjak SA; Casturi SR; Datla SR; Mamidi RN; Mullangi R; Bhamidipati R; Ramanujam R; Akella V; Yeleswarapu KR
    Org Biomol Chem; 2004 Sep; 2(17):2442-50. PubMed ID: 15326524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents.
    Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Alam MS
    Eur J Med Chem; 2011 Dec; 46(12):5763-8. PubMed ID: 22019186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
    Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
    Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat.
    Coppelli G; Guaita E; Spaggiari S; Coruzzi G
    Dig Liver Dis; 2004 Apr; 36(4):265-70. PubMed ID: 15115339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
    Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
    Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
    Bakr RB; Azouz AA; Abdellatif KR
    J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
    Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
    Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
    Menozzi G; Merello L; Fossa P; Mosti L; Piana A; Mattioli F
    Farmaco; 2003 Sep; 58(9):795-808. PubMed ID: 13679172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.
    Abdur Rahim M; Praveen Rao PN; Bhardwaj A; Kaur J; Huang Z; Knaus EE
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6074-80. PubMed ID: 21890358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
    Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.